Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Find out which cash back cards offer the best options for 2023. Stay updated with the latest offerings to maximize your rewards.
26,992 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
In March 2026, smart japan investors choosing hedged exposure via DXJ are gaining ground as currency moves and reform...
Analysts project a multi-year path for novo nordisk (nvo) stock, supported by strong product momentum but tempered by...
Weeks after elon musk called anthropic, SpaceX lands a $4 billion data center deal with Anthropic, signaling a shift ...
Adobe's AI push lifts revenue and unlocks upside for investors as shares hover near $253. This adobe price prediction...
A veteran market strategist argues the semiconductor rally is supported by real demand and capacity constraints, not ...
The U.S. government has imposed export controls on Anthropic’s Fable and Mythos, effectively creating a licensing reg...
MicroStrategy's crypto treasury, dubbed Strategy, remains substantially underwater as Saylor signals another bitcoin ...
As SpaceX prepares to debut on the public market, analysts clash over whether the company is fairly valued amid volat...
As gray divorce cases rise, financial planners warn a simple 50/50 split of retirement accounts often undercuts long-...
As four years after russia began its invasion, the war has sharpened economic stress on households and markets. Drone...
Global markets tumble as President Trump’s policy shifts on Iran fuel uncertainty. Investors scramble to gauge exit p...